| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 434.63B | 431.83B | 422.67B | 406.45B | 398.37B | 408.96B |
| Gross Profit | 80.95B | 77.29B | 68.83B | 53.29B | 46.08B | 21.09B |
| EBITDA | 34.93B | 32.73B | 27.97B | 16.46B | 11.13B | -18.76B |
| Net Income | 8.62B | 17.86B | 42.06B | 19.81B | 11.85B | -23.68B |
Balance Sheet | ||||||
| Total Assets | 229.05B | 216.63B | 205.00B | 166.55B | 145.43B | 161.71B |
| Cash, Cash Equivalents and Short-Term Investments | 105.56B | 88.51B | 68.63B | 53.56B | 45.72B | 54.96B |
| Total Debt | 31.53B | 31.63B | 30.88B | 31.85B | 33.04B | 35.41B |
| Total Liabilities | 124.90B | 128.35B | 133.32B | 133.63B | 134.40B | 158.43B |
| Stockholders Equity | 98.19B | 81.66B | 64.15B | 24.40B | 1.43B | -8.11B |
Cash Flow | ||||||
| Free Cash Flow | 24.51B | 25.56B | 21.10B | 9.94B | -5.95B | -43.65B |
| Operating Cash Flow | 24.85B | 25.90B | 21.42B | 10.54B | -4.46B | -40.82B |
| Investing Cash Flow | -604.00M | -604.00M | 851.00M | 906.00M | 886.00M | 11.83B |
| Financing Cash Flow | -6.40B | -6.40B | -7.12B | -2.82B | -5.89B | 23.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $892.50B | 15.45 | 10.73% | 2.94% | -19.09% | 16.31% | |
73 Outperform | ¥134.64B | 8.22 | 17.98% | 2.93% | 84.20% | 137.87% | |
73 Outperform | ¥4.99T | 22.46 | 8.82% | 0.97% | 0.49% | 12.19% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | ¥1.56T | 13.75 | 12.91% | 3.25% | 45.15% | 19.80% | |
58 Neutral | ¥232.55B | 19.49 | 22.14% | 1.49% | 2.50% | -71.61% | |
57 Neutral | ¥1.05T | 18.02 | 8.38% | 3.68% | 3.52% | -17.58% |
Leopalace21 reported strong financial results for the first nine months of the fiscal year ending March 31, 2026, with net sales of JPY332.7 billion, operating profit of JPY28.6 billion, recurring profit of JPY27.8 billion, and net income of JPY10.0 billion. These figures exceeded the company’s internal plan across all major profit lines, underscoring solid performance in its Leasing and Development businesses and suggesting a favorable trajectory for profitability and operational stability.
Management highlighted that both leasing operations and development activities contributed to the upside versus plan, indicating resilient demand for the company’s rental housing and related services. The stronger-than-expected results may enhance Leopalace21’s financial flexibility and support its competitive position in Japan’s rental housing market, with positive implications for stakeholders monitoring its ongoing business recovery and growth prospects.
The most recent analyst rating on (JP:8848) stock is a Hold with a Yen786.00 price target. To see the full list of analyst forecasts on Leopalace21 stock, see the JP:8848 Stock Forecast page.
Leopalace21 reported net sales of ¥332.7 billion for the nine months ended December 31, 2025, up 2.7% year on year, with operating profit rising 12.5% and recurring profit up 11.8%, while net income attributable to shareholders fell 34.9% to ¥10.0 billion as comprehensive income also declined. The company’s equity ratio dropped sharply to 20.6% from 37.5% at the last fiscal year-end amid a reduction in total assets and net assets, but management kept its full-year earnings and dividend forecasts unchanged, signaling confidence in achieving modest sales and profit growth despite weaker earnings per share and a rising treasury stock balance.
For the fiscal year ending March 31, 2026, Leopalace21 projects net sales of ¥444.1 billion and operating profit of ¥34.8 billion, representing 2.8% and 19.1% growth, respectively, although full-year net income is expected to decline 27.2% to ¥13.0 billion. The company plans to maintain an annual dividend of ¥10.00 per share, suggesting a continued focus on shareholder returns even as capital structure indicators soften, a stance that will be closely watched by investors assessing its financial resilience and long-term strategy.
The most recent analyst rating on (JP:8848) stock is a Hold with a Yen778.00 price target. To see the full list of analyst forecasts on Leopalace21 stock, see the JP:8848 Stock Forecast page.
Leopalace21 has agreed a new ¥30 billion term loan with Mizuho Bank to refinance an existing borrowing of the same amount, aiming to strengthen its financial base through revised terms and conditions. The unsecured facility, running from February 2026 to February 2029 at JPY Tibor plus 1.10%, includes financial covenants requiring non-negative operating and recurring profits and a net debt-to-EBITDA ratio not exceeding five times, with management expecting only minimal impact on current-year earnings and a roughly ¥0.7 billion reduction in interest expenses next fiscal year versus extending the prior loan.
The new loan with Mizuho Bank tightens Leopalace21’s financial discipline by embedding performance-linked covenants that effectively commit the company to maintain profitability and leverage within defined limits. This refinancing is set to modestly lower funding costs while signalling to stakeholders, including creditors and shareholders, that the company is prioritizing balance sheet resilience and more sustainable long-term financing terms.
The most recent analyst rating on (JP:8848) stock is a Hold with a Yen778.00 price target. To see the full list of analyst forecasts on Leopalace21 stock, see the JP:8848 Stock Forecast page.
Leopalace21 will transfer the rights and obligations related to 22 fee-based nursing homes in its Elderly Care Business to its wholly owned subsidiary Azu Residence Co., Ltd. through a simplified absorption-type company split effective April 1, 2026, and will implement a capital increase at Azu Residence. This internal reorganization is designed to clarify management challenges in the Elderly Care Business and enable Azu Residence to improve profitability and operational efficiency, with the capital increase elevating Azu Residence to the status of a specified subsidiary while having no impact on Leopalace21’s own capital or requiring shareholder approval, and the company states it foresees no issues in meeting post-split obligations.
The most recent analyst rating on (JP:8848) stock is a Hold with a Yen704.00 price target. To see the full list of analyst forecasts on Leopalace21 stock, see the JP:8848 Stock Forecast page.